This just in Thursday from the NY Times.
Study of Two Cholesterol Drugs Finds One Halts Heart Disease
By GINA KOLATA
The first study to compare two powerful cholesterol-lowering drugs
head-to-head in treating coronary artery disease finds that one appears to
be superior.
This must have some execs running around calling for damage control!
gregg
Doesn't surprise me coming from Pfizer... they face heavy competition in
this small third world country, where many brands for
atorvastatine-sildenafil-sertraline are marketed and I personally find them
at least equally effective and obviously not toxic. Of course local rep says
the opposite but they don't even visit doctors to promote their products.
Like Roche BTW, and since recently Novartis too.
< This message was delivered via the Olympus Mailing List >
< For questions, mailto:owner-olympus@xxxxxxxxxxxxxxx >
< Web Page: http://Zuiko.sls.bc.ca/swright/olympuslist.html >
|